{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["18"],"submitter":["Kozlowska K"],"pubmed_abstract":["<h4>Background</h4>Insulinomas are the most common functional pancreatic neuroendocrine tumors (pNETs). Minimally invasive approaches like endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) and ethanol ablation (EUS-EA) are emerging treatment options for small insulinomas (<2 cm).<h4>Objectives</h4>To assess the safety, efficacy, and long-term outcomes of EUS-RFA and EUS-EA in treating small pancreatic insulinomas.<h4>Design</h4>A retrospective, single-center study of nine patients diagnosed with insulinomas and treated with EUS ablation methods.<h4>Methods</h4>Nine lesions (mean size 11 mm; range: 6-19 mm) were treated with EUS-RFA (<i>n</i> = 7) or EUS-EA (<i>n</i> = 2). EUS-RFA procedures had a mean ablation time of 31 s (range: 17-69 s), while EUS-EA used a mean ethanol vol"],"journal":["Therapeutic advances in gastrointestinal endoscopy"],"pagination":["26317745251401315"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12708985"],"repository":["biostudies-literature"],"pubmed_title":["EUS-guided radiofrequency and ethanol ablation of pancreatic insulinomas: a single-center experience."],"pmcid":["PMC12708985"],"pubmed_authors":["Wiechowska-Kozlowska A","Bosy-Gasior W","Hsino-Sito N","Kozlowska K","Pawlak KM","Jedruszek S"],"additional_accession":[]},"is_claimable":false,"name":"EUS-guided radiofrequency and ethanol ablation of pancreatic insulinomas: a single-center experience.","description":"<h4>Background</h4>Insulinomas are the most common functional pancreatic neuroendocrine tumors (pNETs). Minimally invasive approaches like endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) and ethanol ablation (EUS-EA) are emerging treatment options for small insulinomas (<2 cm).<h4>Objectives</h4>To assess the safety, efficacy, and long-term outcomes of EUS-RFA and EUS-EA in treating small pancreatic insulinomas.<h4>Design</h4>A retrospective, single-center study of nine patients diagnosed with insulinomas and treated with EUS ablation methods.<h4>Methods</h4>Nine lesions (mean size 11 mm; range: 6-19 mm) were treated with EUS-RFA (<i>n</i> = 7) or EUS-EA (<i>n</i> = 2). EUS-RFA procedures had a mean ablation time of 31 s (range: 17-69 s), while EUS-EA used a mean ethanol vol","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Jan-Dec","modification":"2026-06-08T05:08:55.745Z","creation":"2026-06-08T03:09:10.161Z"},"accession":"S-EPMC12708985","cross_references":{"pubmed":["41415532"],"doi":["10.1177/26317745251401315"]}}